Xenon Recovery at Room Temperature using Metal-Organic Frameworks by Elsaidi, Sameh K. et al.
 1 
Anesthetic Gas DOI:  
Xenon Recovery at Room Temperature using Metal Organic Frameworks 
 Sameh K. Elsaidi, Daniele Ongari, Wenqian Xu, Mona H. Mohamed,  Maciej Haranczyk and 
Praveen K. Thallapally* 
Abstract:  Xenon is known to be a very efficient anesthetic gas but its cost 
prohibits the wider use in medical industry and other potential applications. 
It has been shown that Xe recovery and recycle from anesthetic gas mixture 
can significantly reduce its cost as anesthetic. The current technology uses 
series of adsorbent columns followed by low temperature distillation to 
recover Xe, which is expensive to use in medical facilities. Herein, we propose 
a much simpler and more efficient system to recover and recycle Xe from 
exhale anesthetic gas mixture at room temperature using metal organic 
frameworks (MOFs). Among the MOFs tested, PCN-12 exhibits 
unprecedented performance with high Xe capacity, Xe/O2, Xe/N2 and Xe/CO2 
selectivity at room temperature. The in-situ synchrotron measurements 
suggest that Xe is occupies the small pockets of PCN-12 compared to 
unsaturated metal centers (UMCs). Computational modeling of adsorption 
further supports our experimental observation of Xe binding sites in PCN-12.  
Xenon (Xe) is obtained at an industrial scale as a by-product in the 
fractional distillation of air. Xe has several applications including 
lighting, medical imaging, plasma cleaning in semiconductor industry 
and as anesthetic gas in medical industry.[1] Though Xe is not  
routinely used as anesthetic, several studies suggests the advantages 
of Xe as an alternate to currently used anesthetic gases because of its 
cardiovascular stability, neuroprotection and favorable 
pharmacokinetics, low toxicity, inertness, and environmental 
friendliness.[2] However, the major challenge for the wide use of Xe 
as anesthetic in medical industry is cost.[3] High purity Xe, for 
example, sells for more than $5,000 per kilogram which excludes the 
use of Xe in medical industry. Therefore, Xe recovery and recycle 
was proposed as a viable option for clinical anesthetic purposes.  
In this regard, several technologies have been proposed and 
developed as a portable Xe recycling devices[4] For example, 
anesthetic gas mixture consisting of 65% Xe, 27% O2, 5% CO2 and 
3.3% N2 was passed through a column containing soda lime to remove 
CO2 followed by compressing  the Xe, N2 and O2 at high pressure (66 
bar) to liquefy the Xe. The liquefied Xe was transferred and re-used 
as anesthetic gas.[4] Similarly, an alternate approach was developed 
by Russian scientists in which anesthetic gas mixture was passed over 
the series of activated carbon beds that kept at 77K.[5] The column 
was allowed to warm up slowly so that Xe boils off first which was 
transferred, stored and reused.[5] Membranes have been used for Xe 
recovery and recycle, but still fall short interms of separation 
efficiency and selectivity.[6] The energy and capital-intensive 
separation process used in large-scale production of Xe is 
prohibitively expensive for many small-scale renewable applications 
such as medical and semiconductor industry. Therefore, there is an 
urgent need for alternative technologies and novel materials for 
energy- and cost-efficient Xe recycle and recovery.  
Herein we report for the first time the room temperature Xe recovery 
and recycle using MOFs [7]  that could potentially change the way the 
medical industry administeres anesthetic gas (Figure 1).  
 
 
Figure 1. Schematic representation of Xe recycle and recovery using 
MOFs at room temperature.  
Over the past few years, we and others demonstrated the use of MOFs 
for selective separation of Xe and Kr from each other and from gas 
mixtures relevant to nuclear reprocessing plants at room 
temperature.[8] The best performing adsorbents under nuclear re-
reprocessing conditions are those that pore size matches exactly with 
the kinetic diameter of Xe and/or Kr and have low surface area. For 
example, SBMOF-1,[8g] CROFOUR-1[8f], CC3[9] and Noria[10] 
sorbents have demonstrated to remove Xe selectively from dry and 
wet air (SBMOF-1) at room temperature. However the small pore 
MOFs reported by us and others are not ideal for this application 
because of low adsorption capacity of Xe at 0.65 bar (typical 
composition of Xe gas in anesthetic gas mixture). Though SBMOF-1 
is hydrophobic there is no or very trace amount of water in the exhale 
mixture. Our approach is to remove the water vapor (if present) and 
pass the dry anestetic gas mixture through the adsorbent to selectively 
remove Xe over CO2, N2, and O2. To demonstrate the applicability of 
MOFs for Xe recovery and recycle from anesthetic  gas mixture, we 
selected two benchmark MOFs (NiDOBDC and HKUST-1) that are 
easy to synthesize and scale up, and PCN-12[11] because of its high 
gravimetric internal surface which is in the top 10% among the 5109 
structures of the CoRE MOF database.[12] These three MOFs, 
highlighted in Figure 2, feature high surface area, large pore volume 
and high density of unsaturated metal centers (UMCs). HKUST-1 
possesses three different types of connected cavities; the first is 
located in the middle of the unit cell with pore limiting diameter 
(PLD) of 11 Å which is connected to slightly larger cage with 13 Å 
PLD, while the third is a small tetrahedral cavity with 5 Å PLD (see 
Figure 2 and Figure S1-2).  
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Figure 2. Crystal structure of the MOFs under consideration: (a) 
PCN-12 top view and (b) side view, (c) HKUST-1 and (d) NiDOBDC. 
The favorable adsorption sites are represented in blue: 
opaque/transparent isovalue surfaces correspond to Xe atom-host 
interaction energy of -25/-20 kJ/mol for PCN-12, -30/-20 kJ/mol for 
HKUST-1 and -20/15 kJ/mol for NiDOBDC. 
 
PCN-12 contains two types of pores, one is cage-like which is located 
in the center of the unit cell with opening window of 7.8 Å which 
leads to internal large spherical cage that is connected to small 
pockets to form cuboctahedron-like cage with 21.7 Å PLD. The other 
types of pores are channel-like, two channels across the c- axis: one 
is narrow channel with 7.7 Å PLD and the other is a large channel 
with 14.5 Å PLD. NiDOBDC consists of 1D hexagonal channels with 
13.6 Å PLD. Along the hexagonal channels, the metal nodes form 
stripes where each node connects three channels and each hexagonal 
channel is decorated with Ni UMCs, situated at its vertexes and 6.8 Å 
apart. All the MOFs were freshly prepared using modified reported 
procedures (see Methods Section for more details). Prior to the gas 
sorption measurements, all the samples were activated under vacuum 
at 150 °C. The permanent porosity of NiDOBDC, HKUST-1 and 
PCN-12 was confirmed by N2 adsorption measurements at 77 K that 
revealed a Brunauer–Emmett–Teller (BET) surface area of 1143, 
2014 and 2700 m2g-1 (see Figures S3-8). Single component gas 
adsorption isotherms for Xe, CO2, N2 and O2 gases were collected at 
298 K from 0-1 bar (Figure 3a-c). Xe capacity for NiDOBDC, 
HKUST-1 and PCN-12 at 1 bar and 298 K were found to be 4.26, 
4.33 and 5.12 mmol/g compare to SBMOF-1 (1.2 mmol/g) an almost 
4X higher for PCN-12 over SBMOF-1. The adsorption of Xe in these 
sorbents are much higher than any other sorbents reported thus far 
under this condition. Figure 3a-c reveals the high affinity of 
NiDOBDC, HKUST-1 and PCN-12 towards Xe over nitrogen and 
oxygen gases at 298 K. PCN-12 and HKUST-1 showed preferential 
adsorption of Xe over CO2. Conversely, NiDOBDC preferentially 
adsorbed CO2 over Xe (see Figure 3a-c). HKUST-1 and NiDOBDC 
exhibit Xe uptake of 3.7, 3.0 and 3.5 mmol/g at 0.65 bar. Nevertheless, 
NiDOBDC exhibits higher N2 and O2 uptakes which significantly 
diminish its Xe over N2 and O2 selectivity compared to HKUST-1 and 
PCN-12.   
To fairly compare these materials, column breakthrough experiments 
were conducted using 65% Xe, 24% O2, 6% N2 and 5% CO2 gas 
mixture in order to evaluate the likelihood of employing these 
materials for practical Xe recovery and recycle from anesthetic gas 
mixture. The column packed with these three materials were fed with 
an anesthetic gas mixture at room temperature with flow rate of 5 
ml/min and total pressure of 1 bar. As shown in Figure 3d-f, Xe is 
retained by PCN-12 and HKUST-1 materials while CO2, N2 and O2 
gases were broke through the column. Contrary, Xe broke through the 
NiDOBDC-filled column before CO2suggesting stronger interaction 
between CO2 and NiDOBDC MOF.  
 
 
Figure 3. Xe, CO2, N2 and O2 adsorption isotherms collected at 298 K 
for (a) PCN-12, (b) HKUST-1 and (c) NiDOBDC. 65%Column 
breakthrough curves collected at 298 K using a simulant anesthetic 
gas mixture containing 65% Xe, 24% O2, 6% N2 and 5% CO2 for (d) 
PCN-12, (e) HKUST-1 and (f) NiDOBDC. 
It is important that the adsorbent material can capture Xe gas in a pure 
form without any traces of the competing gases. From the 
breakthrough measurement, PCN-12 showed the highest performance 
of Xe recovery from anesthetic gas mixture. The calculated capacity 
of adsorbed Xe at the breakthrough time by PCN-12 was found to be 
4.4 mmol/g compared to 3.62 and 2.62 mmol/g for HKUST-1 and 
NiDOBDC respectively (see Table 1 and Figure 3d-f). Interestingly, 
PCN-12 and HKUST-1 exhibit high Xe/CO2, Xe/N2 and Xe/O2 
selectivity at 298 K and a total pressure of 1 bar (see Table 1). 
Assuming human air consumption of 500L/h during a 6h surgery, 
capturing Xe from the exhaled air would require only 19.7kg of PCN-
12 sorbent, hence the sorption unit could be quite portable and cheap. 
These results demonstrate the feasibility of MOFs in particular PCN-
12 for efficient and portable Xe recycling and recovery device that 
separate and capture Xe from anesthetic gas mixture at ambient 
condition.  
In order to understand the selectivity of PCN-12 towards Xe, in-situ 
synchrotron Powder X-ray diffraction (PXRD) experiments were 
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performed to resolve the locations of the Xe within the structure at 
298 K under 1 bar Xe (Figure 4 and Figure S9-10). A structure model 
with 15 Xe sites is proposed based on Rietveld refinement and each 
site has an occupancy of 0.15 to 0.6. The total number of Xe 
molecules per unit cell is about 50.  The Xe molecules reside closely 
to the framework inside the small and medium size cages, while the 
largest cavity does not hold Xe at an amount observable by XRD. 
These results are consistent with the observation made in HKUST-1 
where the Xe prefers to occupy or bind to small pockets over 
UMCs.[13] 
We simulated the adsorption of Xe, N2, O2 and CO2 in the three MOFs 
in order to investigate the adsorption sites for Xe and to understand 
the different affinities of the gasses with the frameworks. Nitrogen 
and oxygen are confirmed to adsorb much more weakly than Xe and 
CO2, with their heat of desorption being roughly the half of the second 
two gasses (Figure S11). On the other side xenon and carbon dioxide 
bind to the framework with a comparable strength. In NiDOBDC, we 
can note that the adsorption of CO2 is competing with Xe: in both 
cases the preferential adsorption sites are close to the UMC. This can 
be seen for Xe in Figure 2d, and was already reported from DFT 
calculations. PCN-12 and HKUST-1 are both composed of copper 
paddle-wheel metallic nodes. These copper cations provide a very 
favourable binding site for CO2, but they do not show a strong 
interaction with Xe.[13] The carboxylic linkers are then the major 
responsible for the adsorption of the Xe atoms within the framework, 
through van der Waals interactions, and are well described by the 
force field we used to model the guest-framework interactions: the Xe 
atoms position refined inside the PCN-12 structure result to be mainly 
situated in the strong-binding regions (Figure 4c,d). Hence, from the 
comparison between PCN-12 and HKUST-1 we can expect that the 
higher surface area of the first one is able can accommodate more Xe 
atoms. This leads consequently to a higher Xe capacity for PCN-12 
at the breakthrough time even if HKUST-1 is more selective for 
Xe/CO2, as seen in Table 1.  
We further computed the adsorbed composition of the quaternary 
mixture employed for the column breakthrough measurement using 
the Grand Canonical Monte Carlo method. Table 2 reports the uptake 
and the molar composition inside the three different MOFs. One can 
notice the favourable combination of high gas uptake and high Xe 
percentage that makes PCN-12 the most interesting material for this 
application. Single component isotherms and heat of desorption from 
simulations are provided in the supporting simulation.  
Table 1: The Xe recycle and recovery from anesthetic mixture using 
PCN-12, HKUST-1 and NiDOBDC. 
Adsorption and 
Selectivity 
PCN-12  HKUST-1 NiDOBDC 
Surface area (m2/g) 2700 2014 1143 
Xe capacity at 1 bar 
and 298 K (mmol/g)  
5.12 4.33 4.25 
Xe capacity at 0.65 bar 
and 298 K (mmol/g)  
3.7 3.01 3.5 
Xe Capacity at  
breakthrough time 
(mmol/g) 
4.4 3.62 2.62 
Xe/CO2 selectivity
¶ 1.99 2.3 0.34 
Xe/N2 selectivity
¶ 18.46 19.6 1.86 
Xe/O2 selectivity
¶ 18.25 19.1 2.02 
¶ Selectivity calculated from breakthrough experiments at 1 bar 
and 298 K for 65% Xe, 24% O2, 6% N2 and 5% CO2 gas mixture. 
Capacity from the pure gas adsorption isotherms.        
 
 
  
Figure 4. a) Crystal structure of PCN-12 showing the different cages 
in red, green and light green. b) Xe-loaded crystal structure of PCN-
12 in [001] and [010] direction from in-situ XRD collected at 298K. Xe 
are colored in cyan. c-d) The isovalue surface for the Xe-framework 
interaction is also displayed in blue, corresponding to an interaction 
energy of -12 kJ/mol 
Table 2: Uptake and molar composition for the adsorbed mixture 
used for the breakthrough experiments (for 65% Xe, 24% O2, 6% N2 
and 5% CO2) at 298 K and 1 bar, computed from Grand Canonical 
Monte Carlo simulations.  
 PCN-12  HKUST-1 NiDOBDC 
Uptake (mmol/g) 3.94 2.56 4.25 
Xe (molar %) 89.90% 91.45% 49.19% 
O2 (molar %) 1.92% 2.24% 0.98% 
N2 (molar %) 0.40% 0.49% 0.23% 
CO2 (molar %) 7.77% 5.82% 49.59% 
 
In summary, we have shown the proof-of-principle for Xe recovery 
and recycle from anesthetic gas mixture using metal organic 
frameworks. Among the MOFs tested, PCN-12 was found to exhibit 
remarkable performance for Xe separation and recovery as 
exemplified by the superior Xe adsorption capacity and Xe/CO2, 
Xe/N2 and Xe/O2 selectivity at conditions relevant to anesthetic gas 
mixture recycling. Further, in-situ synchrotron measurements suggest, 
the Xe prefers to bind smaller pockets over UMCs. A closed system 
containing MOF as novel sorbent for portable breathing units for 
medical industry provides an opportunity to recycle and reuse Xe 
efficiently that offers distinct cost-advantage for the widespread use 
of Xe as a source of anesthetic gas.  
Experimental  
Synthesis of HKUST-1:  
10 mmol of trimesic acid was dissolved in 25 ml methanol and slowly 
added to 25 ml methanolic solution of Cu(NO3)2.6H2O (20 mmol). The 
mixture was stirred for 5 min and left on stand for 24 h. Fine blue 
powder was harvested by centrifugation and exchanged with methanol 
for 3 days (2 times/day) prior the activation. 
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Synthesis of NiDOBDC/ MOF-74-Ni: 
In a Teflon autoclave, 10 mmol of 2,5-dihydroxyterephthalic acid and 
15 mmol of Ni(NO3)2.6H2O were dissolved in DMF/Ethanol (50 ml:10 
ml), the reaction mixture then heated for 3 days at 100 °C. Yellow 
powder was harvested by centrifugation and exchanged with methanol 
for 3 days (2 times/day) prior the activation. 
 
Synthesis of PCN-12: 
PCN-12 has been synthesized by the solvothermal reaction of 
Cu(NO3)2.2.5H2O and 3,3',5,5'-tetracarboxydiphenylmethane, 
H4(mdip), in dimethylacetamide (DMA) at 85 °C. The blue powder 
product was isolated after 48 hr and exchanged with methanol.  All 
structures were characterized by PXRD (see Figures S3-5). 
 
Adsorption Experiments: 
Xe, CO2, N2 and O2 sorption experiments at were performed using an 
automatic gas sorption analyzer (Quantachrome Autosorb IQ, 
Quantachrome Instruments, Dayton Beach, FL). In each experiment, 
about 200-500 mg of solid sample was loaded prior activation. Each 
sample was activated at 150 °C under dynamic pressure for 12 
hours and then brought to the sorption temperature. 
 
Column Breakthrough Experiments: 
Experimental column breakthrough measurements were conducted by 
packing the MOF sample in a 6.35-cm long and 0.5-cm diameter 
column. The sample was activated at a proper temperature. 
Pressurization of the column-containing MOF was accomplished by 
syringe pump (Teledyne ISCO) directly connected to the system. An 
inline pressure transducer was used to verify column pressure. The 
column was cooled to room temperature and the pure He gas was 
initially flowed to a Stanford Research Residual Gas Analyzer (RGA) 
for first three minutes, after which the flow of He is stopped and flow of 
the simulant anesthetic gas mixture (65% Xe, 24% O2, 6% N2 and 5% 
CO2) is introduced to the fixed bed column containing the MOF sample 
with flow rate of 5 ml/min and total pressure of 1 bar at room 
temperature. Effluent gases were thereby tracked with the RGA, while 
the gases breaking through the column were indicated by an increase 
in the pressure. The experimental set-up of the column breakthrough 
experiment is presented in Scheme S1. 
 
Simulations: 
The structures were hold rigid and dispersion interactions were 
modelled combining different sets of parameters: UFF[14] for the 
frameworks’ atoms, TraPPE[15] for N2 and O2, and for Xe we employed 
the parameters from Potoff et al..[16] Point charge were derived using 
the EQeq method.[17] For CO2 we referred to tailor made 
parametrizations as specified in the Supporting Information. Raspa 2.0 
package[18] was employed to perform the Grand Canonical Monte Carlo 
simulations and to compute the plot of Xe adsorption sites in the 
frameworks.  
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use in medical industry and other potential applications. It has been shown that Xe 
recovery and recycle from anesthetic gas mixture can significantly reduce its cost 
as anesthetic. The current technology uses series of adsorbent columns followed 
by low temperature distillation to recover Xe, which is expensive to use in medical 
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